Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,916 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates.
He W, Ou T, Skamangas N, Bailey CC, Bronkema N, Guo Y, Yin Y, Kobzarenko V, Zhang X, Pan A, Liu X, Xu J, Zhang L, Allwardt AE, Mitra D, Quinlan B, Sanders RW, Choe H, Farzan M. He W, et al. Among authors: pan a. Immunity. 2023 Oct 10;56(10):2408-2424.e6. doi: 10.1016/j.immuni.2023.07.003. Epub 2023 Aug 1. Immunity. 2023. PMID: 37531955 Free PMC article.
In vivo affinity maturation of the CD4 domains of an HIV-1-entry inhibitor.
Pan A, Bailey CC, Ou T, Xu J, Aristotelous T, Liu X, Hu B, Crynen G, Skamangas N, Bronkema N, Tran MH, Mou H, Zhang X, Alpert MD, Yin Y, Farzan M, He W. Pan A, et al. Nat Biomed Eng. 2024 Dec;8(12):1715-1729. doi: 10.1038/s41551-024-01289-1. Epub 2024 Dec 5. Nat Biomed Eng. 2024. PMID: 39638875
In vivo affinity maturation of the HIV-1 Env-binding domain of CD4.
Pan A, Bailey CC, Ou T, Xu J, Liu X, Hu B, Crynen G, Skamangas N, Bronkema N, Tran M, Mu H, Zhang X, Yin Y, Alpert MD, He W, Farzan M. Pan A, et al. bioRxiv [Preprint]. 2024 Feb 5:2024.02.03.578630. doi: 10.1101/2024.02.03.578630. bioRxiv. 2024. PMID: 38370774 Free PMC article. Preprint.
Leveraging cancer mutation data to inform the pathogenicity classification of germline missense variants.
Haque B, Cheerie D, Pan A, Curtis M, Nalpathamkalam T, Nguyen J, Salhab C, Thiruvahindrapuram B, Zhang J, Couse M, Hartley T, Morrow MM, Price EM, Walker S, Malkin D, Roth FP, Costain G. Haque B, et al. Among authors: pan a. PLoS Genet. 2025 Jan 6;21(1):e1011540. doi: 10.1371/journal.pgen.1011540. Online ahead of print. PLoS Genet. 2025. PMID: 39761285 Free article.
1,916 results